Cellect Laboratories

Problem: Traditional cervical cancer and HPV screenings are invasive, uncomfortable, and inaccessible for many—creating barriers for trauma-sensitive, culturally restricted, and hesitant individuals—leading to delayed detection and preventable health outcomes. Solution: CELLECT provides a non-invasive diagnostic solution using a nanotechnology-engineered collection device embedded in menstrual products. It extracts and stabilizes viral DNA and cervical & epithelial cells for gold-standard HPV testing, offering accessible, affordable, and efficient screening for cervical cancer & other reproductive health conditions Target Markets: Diagnostic Labs, Healthcare Providers, Public Health Program Looking for business opportunities in: Investor, Mentor, Market Access, Business Expertise, Non-dilutive Funding Technology Readiness Level: TRL 3-4 Experimental Proof of Concept Contact info: Ibukun Elebute cellectlaboratories@gmail.com www.cellectlaboratories.com